Opdivo Makes Waves in Colorectal Cancer

Interesting article about BMS expanding Opdivo’s colorectal cancer indication. Which companies could be impacted by this expansion? Kognitic’s platform can show you which companies have new drugs in the pipeline for colorectal cancer in seconds! Kognitic employs Machine Learning and Natural Language Processing to automatically capture every drug undergoing a clinical trial, as well as the design of the trial and its indication. Kognitic’s platform then organizes this data so that clients may quickly and effortlessly access any information of interest and presents the data via stunning visual analytics.

Bristol-Myers Squibb, Bayer team up on Opdivo-Stivarga combo in colorectal cancer https://lnkd.in/gDQZE5D